Biomagnetics Diagnostics Corp. needs no formal introduction. It is an advanced medical company and biotechnology company and well known for its revolutionary diagnostic tools. Through its subsidiary, Bio-spectrum Technologies, the company is holding patented technologies that have regenerated the stem cell, genetic engineering and biotechnology industries. The company also holds patented technologies to bring about reliable and trustworthy diagnostic tools in covering a wide range of bacterial and viral assays. Apart from that the company was issued two important patents related to Systems and Methods for Biochemical Assay in 2003 and 2006 which paved the way for a wider range of applications in both testing and diagnosis. Apart from that they were also issued with a third patent for a new kind of diagnostic system related to multi analytic testing for blood banks.
Biomagnetics Diagnostics Corporation makes use of advanced magnetics to create revolutionary diagnostic systems. With this technology they are able to test for any viral or bacterial disease at a high rate. They perform all the tests within the shortest time possible when other laboratories perform just one of a series of tests. So rapid are the test results that diagnosis and treatment will be started as soon as symptoms are detected. The labs use any type of fluids for their test namely, blood, urine, saliva, tears, hormonal fluids and even spinal fluids. They use an innovative product, High Throughput Screening – Magnetic Testing Platform (HTS-MTP) for the purpose. This equipment detects the target virus first by measuring then defining a single paramagnetic micro-sphere attached to each virus molecule. This is done within a fraction of time and doesn’t even cost half of what other immuno assays (chemical method for detecting infections) in use cost. This technology detects the virus and the extent of virus load within minutes and it can even screen many more assays per hour. And it is expected to work with 100% accuracy. HTS-MTP uses both qualitative and quantitative analysis. Qualitative refers to the chemical identifications of elements in a substance; and quantitative refers to the specific number of elements in a given substance. HTS-MTP technology has taken the world by storm because of its cost effective feature HTS-MTP technology is extremely popular with blood banks everywhere.
Biomagnetics Diagnostics Corp. has been relentlessly pursuing methods to detect certain fatal diseases. According to the reports by World Health Organization, about half the people in the world in around 107 countries is at risk of getting infected with the dreaded disease malaria. The number of malaria infected cases that are reported yearly is staggering; more or less 500 million new cases every year. The reason for this is the lack of reliable and deployable diagnostic tools. Early detection is very crucial in diseases like malaria because chances of treatment and survivability depended wholly on early detection. Bovine TB in cattle is another major cause for concern. It brings a major loss for the cattle industry and those nations thriving on it. Tuberculosis is another dreaded disease and the second most death causing infectious disease. This is where Biomagnetics Diagnostics Corp steps in as a life saver. The company has been relentlessly pursuing and experimenting with their technologies and their scientists have come with a solution to detect malaria and tuberculosis much earlier than other lab technologies. The CEO of Biomagnetics Diagnostics Corp., Clayton Hardman, has announced that they plan to enter in to the areas related to malaria and bovine tuberculosis testing. Thus in a short while, Biomagnetics Diagnostics Corp will be ready to introduce into the market field deployable Integrated Optical Biosensor Systems (IBOS) for speed diagnostic testing. IBOS is a relatively new classification of equipment that detects pathogens. It uses advanced fiber optic technology which is capable of detecting pathogens in both humans and animals. Early field detection of malaria and bovine TB has been in demand for so long and it was Biomagnetics Diagnostics Corp. that entered into the field of IBOS for not only those two diseases but other diseases as well.
The company’s management has recognized the potential of Latin American and Asian markets. They plan to focus their first clinical trials in Mexico, Thailand, Sweden, India and China starting this very year. Once the clinical trials are conducted in these countries, they plan to explore USA by 2012. The company is awaiting funds for conducting its clinical experiments. They are already initiating clinical trials in some major hospitals, namely Hospital of Infectologia of the Centro Medico Nacional (CMN) La Raza, Mexico, India’s Health Ministry Blood Bank, Kenya and other countries. With such great news, it is easy to see why Biomagnetics could be the technology of the future.